Total diet replacement vs Wegovy: which is right for you?

Let's compare total diet replacement programmes and Wegovy, including timelines, lifestyle considerations and which might suit you best.



Both approaches can yield significant weight loss, although timelines and experiences may differ.

Research into medically supervised TDR programmes has shown average weight loss outcomes of around 10% to 15% in some structured interventions.¹

Meanwhile, a phase 3 clinical trial involving semaglutide found that Wegovy users lost an average of around 15% of their starting body weight.²

These are both clinically significant results.

Which approach works faster?

In many cases, TDR programmes produce faster initial weight loss.

This is because calorie intake is usually tightly controlled from the beginning, creating a relatively large energy deficit immediately.

Some people find that early progress highly motivating.

For others, rapid weight loss can also feel socially and psychologically challenging, particularly during the adjustment period.

Wegovy tends to work more gradually because the medication is introduced slowly through dose escalation to help manage side effects and improve tolerability.

For some people, this slower pace can feel more manageable and sustainable long-term.

Appetite and hunger

One of the most important practical differences between these approaches is how hunger feels during treatment.

Traditional dieting often becomes difficult because, as calorie intake decreases, appetite increases.

This is where Wegovy may feel different for many people.

Because semaglutide affects appetite-regulating hormones, users often report feeling:

• Less preoccupied with food
• More satisfied with smaller portions
• Less hungry overall
  
  

This can make healthy eating habits feel easier to maintain consistently.

Meanwhile, a TDR programme relies more heavily on structured nutritional planning and behavioural adherence.

Some people enjoy the simplicity and structure this provides. Others may find the rigidity more challenging.

Lifestyle considerations

Different approaches suit different personalities and lifestyles.

Some people thrive with highly structured systems and clear rules. Others prefer more flexibility.

A TDR programme may suit people who:

• Prefer structure and routine
• Feel overwhelmed by food decisions
• Want rapid early progress
• Respond well to accountability and coaching
• Wegovy may suit people who:
• Struggle strongly with appetite or cravings
• Have experienced repeated cycles of dieting and weight regain
• Prefer a more gradual transition
• Want support alongside normal meals and routines
• Need help reducing food preoccupation
  
  

Neither approach is inherently better than the other. The best option is often the one that feels realistic enough to maintain.

Side effects and tolerability

Both approaches involve adjustment periods.

With Wegovy, common reported side effects include:

• Nausea
• Constipation
• Diarrhoea
• Vomiting
• Abdominal discomfort
• These symptoms are often temporary and tend to improve as the body adjusts.
• TDR programmes may also involve side effects initially, especially during early calorie restriction.
• Some people experience:
• Hunger
• Fatigue
• Headaches
• Irritability
• Low energy
  
  

These side effects are one reason why ongoing support and monitoring are so valuable during either approach.

The importance of behavioural support

One of the biggest misconceptions around weight loss is the idea that medically supported programmes work regardless of lifestyle.

In reality, long-term success almost always depends on broader habit changes.

At Semapen, we offer a weight loss medication programme, as well as the SemaHealth TDR programme. Both are designed to work alongside nutritional guidance, behavioural support, progress monitoring and clinical oversight to support sustainable lifestyle changes. 

This is key to success because maintaining long-term weight loss usually involves developing routines that remain manageable after the initial intervention phase.

There is no single 'correct' approach

Both Wegovy and TDR programmes require effort, consistency and behavioural change.

A structured programme, such as SemaHealth, may appeal to people who prefer routine, nutritional structure and faster initial progress. Wegovy, meanwhile, may suit individuals who struggle more strongly with appetite, cravings or repeated cycles of dieting and regain.

The most effective weight loss plan is unlikely to be the most challenging one. It's more likely to be the one you can realistically maintain safely and sustainably over time.

Semapen specialises in expert-led, clinically supported weight loss treatments. Learn more about Wegovy or explore the SemaHealth meal replacement weight loss programme.

Sources

1. Valabhji, J. et al. (2024) "Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation" The Lancet Diabetes & Endocrinology, 12(9) https://doi.org/10.1016/S2213-8587(24)00194-3

2. Wilding, J.P.H. et al. (2021) "Once-Weekly Semaglutide in Adults with Overweight or Obesity" The New England Journal of Medicine, 384(11) https://doi.org/10.1056/NEJMoa2032183

This article was reviewed and approved by Lujain Alhassan, Bariatric Nutritionist, on 1 June 2026.